Clinical trial NCT06924827
Status: Not yet recruitingPhase 4Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex
- Record number
- NCT06924827
- Status
- Not yet recruiting
- Type and phase
- Clinical trial, phase 4
- Participants
- Target: 25
- Condition (as registered)
- Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)
- Countries
- Canada
- Topic in the guide
- Dravet Syndrome, Lennox–Gastaut Syndrome
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: January 1, 2027 (expected)
- End of data collection for primary results: January 1, 2028 (expected)
- Trial completion: June 2029 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Not yet recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Dravet Syndrome: ongoing trials · Lennox–Gastaut Syndrome: ongoing trials · Thinking of taking part? Which specialist to see